「de」の検索結果
173件：111～115件目を表示
-
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy
http://www.senju.co.jp/english/about/ -
Company Profile | About Senju | SENJU Pharmaceutical
April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi Sugisawa Managing Officer Member Of BoardMit...
https://www.senju.co.jp/english/about/outline.html -
Mytear ALPITATTO NEXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO NEXα Works on unbearable eye itching due to pollens and other...
https://www.senju.co.jp/english/products/nex.html -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r...
https://www.senju.co.jp/english/products/mytearv.html -
g/mL」に関する販売パートナーシップ契約を締結しましたのでお知らせします。 アイザベイTMはアステラス製薬が日本において萎縮型加齢黄斑変性（Atrophic Age-related Macular Degeneration：萎縮型AMD）における地図状萎縮（Geographic Atrophy：GA）の進 行抑制を効能・効果として発売したファーストインクラスの治療薬です。 GAは、萎縮型AMDの...
https://www.senju.co.jp/index.php/system/files/content_news/2025-11/JPN_20251127.pdf